Amendment #7 to H4530

Coverage for GLP-1's for GIC Employees

Mr. Soter of Bellingham moves to amend the bill by adding the following two sections:

“SECTION XXX. Chapter 32A of the General Laws is hereby amended by inserting after section 17S the following section:

Section 17T. Coverage for GLP-1 Medications.

(a) Any coverage offered by the commission to an active or retired employee of the commonwealth insured under the group insurance commission shall provide coverage for glucagon-like peptide-1 receptor agonist medications (GLP-1s) that have been approved by the United States Food and Drug Administration for: (i) treatment of diabetes; (ii) chronic weight management or obesity; or (iii) any other indication for which such medication has received FDA approval.

(b) Such coverage shall not be restricted to circumstances of “medical necessity” narrower than the FDA-approved indications, nor shall coverage be eliminated or reduced by mid-year plan design changes.

(c) The benefits in this section shall not be subject to any greater deductible, coinsurance, copayments or out-of-pocket limits than any other benefit provided by the commission.

SECTION XXX. Notwithstanding any general or special law to the contrary, the sum of $27,500,000 is hereby appropriated to the Group Insurance Commission for the purpose of implementing section 17T of chapter 32A of the General Laws. This appropriation shall supplement any other amounts appropriated to the commission in said fiscal year and shall be made available until June 30, 2026.”

Additional co-sponsor(s) added to Amendment #7 to H4530

Coverage for GLP-1's for GIC Employees